首页> 美国政府科技报告 >A PRELIMINARY SYSTEMS-ENGINEERING STUDY OF AN ADVANCED NUCLEAR-ELECTROLYTIC HYDROGEN-PRODUCTION

【24h】

A PRELIMINARY SYSTEMS-ENGINEERING STUDY OF AN ADVANCED NUCLEAR-ELECTROLYTIC HYDROGEN-PRODUCTION

机译：一种先进的核电解氢生产的初步系统 - 工程研究

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

The principal components of the advanced-facility concept are —nHigh-temperature gaa-cooled reactor (HTGR) operating a helium-Brayton/ammonia-Rankine binary cycle with a helium reactor-core exit temperature of 980°C (1800°F)nAcyclic d-c generators (obviates rectification)nHigh-pressure, high-current-density electrolyzers based on solid-polymer electrolyte (SPE) technology (obviates mechanical compression).

著录项

作者
William J. D. Escher; Timothy D. Darrow; Alex J. Konopka;
展开▼
作者单位

展开▼
年度 1975
页码 1-101
总页数 101
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词

相似文献

外文文献
中文文献
专利

1. AZD8186 study 1: Phase I study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary anti-tumour activity of AZD8186 in patients with advanced castration resistant prostate cancer (CRPC), squamous non-small cell lung cancer, triple negative breast cancer and with PTEN-deficient/mutated or PIK3CB mutated/amplified malignancies, as monotherapy and in combination with vistusertib (AZD2014) or abiraterone acetate [J] . Lillian S., De Bono J., Higano C., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：AZD8186研究1：I期研究评估AZD8186在晚期去势抵抗性前列腺癌（CRPC），鳞状非小细胞肺癌患者中的安全性，耐受性，药代动力学（PK），药效学（PD）和初步抗肿瘤活性，三联阴性乳腺癌以及PTEN缺陷/突变或PIK3CB突变/扩增的恶性肿瘤，单药治疗并与vistusertib（AZD2014）或醋酸阿比特龙合用
2. AZD8186 study 1: Phase I study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary anti-tumour activity of AZD8186 in patients with advanced castration resistant prostate cancer (CRPC), squamous non-small cell lung cancer, triple negative breast cancer and with PTEN-deficient/mutated or PIK3CB mutated/amplified malignancies, as monotherapy and in combination with vistusertib (AZD2014) or abiraterone acetate [J] . Lillian S., De Bono J., Higano C., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：AZD8186研究1：I期研究，评估AZD8186在先进的阉割前列腺癌（CRPC），鳞状非小细胞肺癌患者中AZD8186的安全性，耐受性，药代动力学（PK），药效学（PD）和初步抗肿瘤活性，三重阴性乳腺癌和PTEN缺乏/突变或PIK3CB突变/扩增的恶性肿瘤，作为单药治疗，与Vistusertib（AZD2014）或乙酸酯组合
3. 6587 POSTER A phase IB, dose-finding study of erlotinib in combination with pemetrexed in patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC): a preliminary analysis of the BP18193 study [J] . M.Ranson, M.Reck, A.Anthoney, European Journal of Cancer Supplements . 2007,第4期

机译：晚期（IIIB / IV期）非小细胞肺癌（NSCLC）患者中6587 POSTER A阶段IB剂量研究，厄洛替尼联合培美曲塞的临床研究：BP18193研究的初步分析
4. Preliminary Study on OBS Electrification Efficiency for Advanced Supersonic Business and Medium Jet with Unified Engines [C] . Artur Mirzoyan, Marco Fioriti, Luca Boggero, AIAA/SAE/ASEE joint propulsion conference;AIAA propulsion and energy forum . 2018

机译：先进超音速商务飞机和中型喷气机联合发动机的OBS电气化效率的初步研究
5. Acceptance of pain: A preliminary study in advanced cancer patients. [D] . Gauthier, Lynn R. 2007

机译：疼痛的接受：对晚期癌症患者的初步研究。
6. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group [O] . Y Segawa, H Ueoka, K Kiura, 2000

机译：顺铂和5-氟尿嘧啶联合超分割胸腔放疗用于局部晚期非小细胞肺癌的II期研究：冈山肺癌研究小组的初步报告
7. 679. Preliminary Safety Results from the IMPACT Study — A Phase 2-3 Clinical Study in Patients with Advanced Colorectal Carcincoma with the Immunomodulator MGN1703 [O] . 2012

机译：679.影响研究的初步安全结果 - 具有免疫调节器MGN1703的晚期结直肠癌患者的2-3阶段临床研究

A PRELIMINARY SYSTEMS-ENGINEERING STUDY OF AN ADVANCED NUCLEAR-ELECTROLYTIC HYDROGEN-PRODUCTION

摘要

著录项

相似文献

相关主题

期刊订阅